A Call for a Three-Tiered Pandemic Public Health Strategy in Context of SARS-CoV-2.
Identifieur interne : 000246 ( Main/Exploration ); précédent : 000245; suivant : 000247A Call for a Three-Tiered Pandemic Public Health Strategy in Context of SARS-CoV-2.
Auteurs : Brian P. Hanley [États-Unis] ; Steve Keen [Royaume-Uni] ; George Church [États-Unis]Source :
- Rejuvenation research [ 1557-8577 ] ; 2020.
Descripteurs français
- KwdFr :
- Appréciation des risques (MeSH), Betacoronavirus (physiologie), Facteurs de risque (MeSH), Humains (MeSH), Infections à coronavirus (immunologie), Infections à coronavirus (prévention et contrôle), Infections à coronavirus (virologie), Infections à coronavirus (épidémiologie), Pandémies (MeSH), Pneumopathie virale (immunologie), Pneumopathie virale (virologie), Pneumopathie virale (épidémiologie), Produit intérieur brut (MeSH), Santé publique (MeSH), Vaccins antiviraux (immunologie).
- MESH :
- immunologie : Infections à coronavirus, Pneumopathie virale, Vaccins antiviraux.
- physiologie : Betacoronavirus.
- prévention et contrôle : Infections à coronavirus.
- virologie : Infections à coronavirus, Pneumopathie virale.
- épidémiologie : Infections à coronavirus, Pneumopathie virale.
- Appréciation des risques, Facteurs de risque, Humains, Pandémies, Produit intérieur brut, Santé publique.
English descriptors
- KwdEn :
- Betacoronavirus (physiology), COVID-19 (MeSH), COVID-19 Vaccines (MeSH), Coronavirus Infections (epidemiology), Coronavirus Infections (immunology), Coronavirus Infections (prevention & control), Coronavirus Infections (virology), Gross Domestic Product (MeSH), Humans (MeSH), Pandemics (MeSH), Pneumonia, Viral (epidemiology), Pneumonia, Viral (immunology), Pneumonia, Viral (virology), Public Health (MeSH), Risk Assessment (MeSH), Risk Factors (MeSH), SARS-CoV-2 (MeSH), Viral Vaccines (immunology).
- MESH :
- chemical , immunology : Viral Vaccines.
- chemical : COVID-19 Vaccines.
- epidemiology : Coronavirus Infections, Pneumonia, Viral.
- immunology : Coronavirus Infections, Pneumonia, Viral.
- physiology : Betacoronavirus.
- prevention & control : Coronavirus Infections.
- virology : Coronavirus Infections, Pneumonia, Viral.
- COVID-19, Gross Domestic Product, Humans, Pandemics, Public Health, Risk Assessment, Risk Factors, SARS-CoV-2.
DOI: 10.1089/rej.2020.2363
PubMed: 32539623
PubMed Central: PMC7462018
Affiliations:
- Royaume-Uni, États-Unis
- Angleterre, Grand Londres, Indiana, Massachusetts
- Londres
- University College de Londres
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A Call for a Three-Tiered Pandemic Public Health Strategy in Context of SARS-CoV-2.</title><author><name sortKey="Hanley, Brian P" sort="Hanley, Brian P" uniqKey="Hanley B" first="Brian P" last="Hanley">Brian P. Hanley</name><affiliation wicri:level="2"><nlm:affiliation>Department of Research and Development, Butterfly Sciences, South Bend, Indiana, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Research and Development, Butterfly Sciences, South Bend, Indiana</wicri:regionArea><placeName><region type="state">Indiana</region></placeName></affiliation></author><author><name sortKey="Keen, Steve" sort="Keen, Steve" uniqKey="Keen S" first="Steve" last="Keen">Steve Keen</name><affiliation wicri:level="4"><nlm:affiliation>Institute for Strategy, Resilience and Security, University College London, London, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Institute for Strategy, Resilience and Security, University College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName><orgName type="university">University College de Londres</orgName></affiliation></author><author><name sortKey="Church, George" sort="Church, George" uniqKey="Church G" first="George" last="Church">George Church</name><affiliation wicri:level="2"><nlm:affiliation>Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Genetics, Harvard Medical School, Boston, Massachusetts</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32539623</idno><idno type="pmid">32539623</idno><idno type="doi">10.1089/rej.2020.2363</idno><idno type="pmc">PMC7462018</idno><idno type="wicri:Area/Main/Corpus">000193</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000193</idno><idno type="wicri:Area/Main/Curation">000193</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000193</idno><idno type="wicri:Area/Main/Exploration">000193</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">A Call for a Three-Tiered Pandemic Public Health Strategy in Context of SARS-CoV-2.</title><author><name sortKey="Hanley, Brian P" sort="Hanley, Brian P" uniqKey="Hanley B" first="Brian P" last="Hanley">Brian P. Hanley</name><affiliation wicri:level="2"><nlm:affiliation>Department of Research and Development, Butterfly Sciences, South Bend, Indiana, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Research and Development, Butterfly Sciences, South Bend, Indiana</wicri:regionArea><placeName><region type="state">Indiana</region></placeName></affiliation></author><author><name sortKey="Keen, Steve" sort="Keen, Steve" uniqKey="Keen S" first="Steve" last="Keen">Steve Keen</name><affiliation wicri:level="4"><nlm:affiliation>Institute for Strategy, Resilience and Security, University College London, London, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Institute for Strategy, Resilience and Security, University College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName><orgName type="university">University College de Londres</orgName></affiliation></author><author><name sortKey="Church, George" sort="Church, George" uniqKey="Church G" first="George" last="Church">George Church</name><affiliation wicri:level="2"><nlm:affiliation>Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Genetics, Harvard Medical School, Boston, Massachusetts</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author></analytic><series><title level="j">Rejuvenation research</title><idno type="eISSN">1557-8577</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Betacoronavirus (physiology)</term><term>COVID-19 (MeSH)</term><term>COVID-19 Vaccines (MeSH)</term><term>Coronavirus Infections (epidemiology)</term><term>Coronavirus Infections (immunology)</term><term>Coronavirus Infections (prevention & control)</term><term>Coronavirus Infections (virology)</term><term>Gross Domestic Product (MeSH)</term><term>Humans (MeSH)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (epidemiology)</term><term>Pneumonia, Viral (immunology)</term><term>Pneumonia, Viral (virology)</term><term>Public Health (MeSH)</term><term>Risk Assessment (MeSH)</term><term>Risk Factors (MeSH)</term><term>SARS-CoV-2 (MeSH)</term><term>Viral Vaccines (immunology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Appréciation des risques (MeSH)</term><term>Betacoronavirus (physiologie)</term><term>Facteurs de risque (MeSH)</term><term>Humains (MeSH)</term><term>Infections à coronavirus (immunologie)</term><term>Infections à coronavirus (prévention et contrôle)</term><term>Infections à coronavirus (virologie)</term><term>Infections à coronavirus (épidémiologie)</term><term>Pandémies (MeSH)</term><term>Pneumopathie virale (immunologie)</term><term>Pneumopathie virale (virologie)</term><term>Pneumopathie virale (épidémiologie)</term><term>Produit intérieur brut (MeSH)</term><term>Santé publique (MeSH)</term><term>Vaccins antiviraux (immunologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Viral Vaccines</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>COVID-19 Vaccines</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term><term>Vaccins antiviraux</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Coronavirus Infections</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Infections à coronavirus</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" xml:lang="en"><term>COVID-19</term><term>Gross Domestic Product</term><term>Humans</term><term>Pandemics</term><term>Public Health</term><term>Risk Assessment</term><term>Risk Factors</term><term>SARS-CoV-2</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Appréciation des risques</term><term>Facteurs de risque</term><term>Humains</term><term>Pandémies</term><term>Produit intérieur brut</term><term>Santé publique</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32539623</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>02</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8577</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>08</Month></PubDate></JournalIssue><Title>Rejuvenation research</Title><ISOAbbreviation>Rejuvenation Res</ISOAbbreviation></Journal><ArticleTitle>A Call for a Three-Tiered Pandemic Public Health Strategy in Context of SARS-CoV-2.</ArticleTitle><Pagination><MedlinePgn>281-283</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1089/rej.2020.2363</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hanley</LastName><ForeName>Brian P</ForeName><Initials>BP</Initials><AffiliationInfo><Affiliation>Department of Research and Development, Butterfly Sciences, South Bend, Indiana, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keen</LastName><ForeName>Steve</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute for Strategy, Resilience and Security, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Church</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Rejuvenation Res</MedlineTA><NlmUniqueID>101213381</NlmUniqueID><ISSNLinking>1549-1684</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName><SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059066" MajorTopicYN="N">Gross Domestic Product</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011634" MajorTopicYN="Y">Public Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32539623</ArticleId><ArticleId IdType="doi">10.1089/rej.2020.2363</ArticleId><ArticleId IdType="pmc">PMC7462018</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nature. 2005 Nov 17;438(7066):355-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16292310</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2015 Jun 26;33(29):3288-92</Citation><ArticleIdList><ArticleId IdType="pubmed">26004568</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Royaume-Uni</li><li>États-Unis</li></country><region><li>Angleterre</li><li>Grand Londres</li><li>Indiana</li><li>Massachusetts</li></region><settlement><li>Londres</li></settlement><orgName><li>University College de Londres</li></orgName></list><tree><country name="États-Unis"><region name="Indiana"><name sortKey="Hanley, Brian P" sort="Hanley, Brian P" uniqKey="Hanley B" first="Brian P" last="Hanley">Brian P. Hanley</name></region><name sortKey="Church, George" sort="Church, George" uniqKey="Church G" first="George" last="Church">George Church</name></country><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Keen, Steve" sort="Keen, Steve" uniqKey="Keen S" first="Steve" last="Keen">Steve Keen</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Wicri/explor/CovidPublicV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000246 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000246 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Wicri
|area= CovidPublicV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32539623
|texte= A Call for a Three-Tiered Pandemic Public Health Strategy in Context of SARS-CoV-2.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32539623" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidPublicV1
| This area was generated with Dilib version V0.6.38. |  |